Stevens Capital Management LP grew its position in Lam Research Co. (NASDAQ:LRCX – Free Report) by 1,720.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,773 shares of the semiconductor company’s stock after purchasing an additional 7,346 shares during the period. Stevens Capital Management LP’s holdings in Lam Research were worth $561,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of LRCX. Financial Perspectives Inc boosted its stake in shares of Lam Research by 908.8% in the fourth quarter. Financial Perspectives Inc now owns 343 shares of the semiconductor company’s stock worth $25,000 after buying an additional 309 shares during the last quarter. Fairway Wealth LLC boosted its stake in shares of Lam Research by 900.0% in the fourth quarter. Fairway Wealth LLC now owns 340 shares of the semiconductor company’s stock worth $25,000 after buying an additional 306 shares during the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. Midwest Capital Advisors LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. Finally, Bell Investment Advisors Inc boosted its stake in shares of Lam Research by 836.6% in the fourth quarter. Bell Investment Advisors Inc now owns 384 shares of the semiconductor company’s stock worth $28,000 after buying an additional 343 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Lam Research
In other news, SVP Seshasayee Varadarajan sold 110,080 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $90.00, for a total transaction of $9,907,200.00. Following the completion of the transaction, the senior vice president now directly owns 179,084 shares in the company, valued at $16,117,560. This trade represents a 38.07 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.29% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on Lam Research
Lam Research Price Performance
LRCX stock opened at $75.84 on Monday. The business has a fifty day moving average of $79.62 and a two-hundred day moving average of $77.29. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51. The stock has a market cap of $97.35 billion, a price-to-earnings ratio of 23.04, a price-to-earnings-growth ratio of 1.47 and a beta of 1.53. Lam Research Co. has a 52-week low of $68.87 and a 52-week high of $113.00.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. As a group, research analysts anticipate that Lam Research Co. will post 3.71 earnings per share for the current year.
Lam Research Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.23 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.92 annualized dividend and a dividend yield of 1.21%. Lam Research’s dividend payout ratio is currently 27.96%.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also
- Five stocks we like better than Lam Research
- Transportation Stocks Investing
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- When to Sell a Stock for Profit or Loss
- 3 ETFs to Ride the VIX Surge During Market Volatility
- How to Use the MarketBeat Excel Dividend Calculator
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.